B3 · BRL
OFSA3
Ourofino S.A.
- Day's range
- R$25.50 – R$25.90
- Day's volume
- R$167.4K
- 52-week range
- R$20.90 – R$34.69
Follow OFSA3 in the Fuolio
See how OFSA3 weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountOFSA3 in numbers
- Market cap
- R$1.4B
- P/E
- 5.88
- P/B
- 1.68
- Dividend yield (12m)
- 5.01%
- Net debt/EBITDA
- 0.47
The 12-month dividend yield of OFSA3 is 5.01%, below its 5-year average of 5.28%.
OFSA3 price history
OFSA3 risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +24.54% | +52.55% | +21.65% |
| Volatility (annualized) | 25.27% | 32.40% | 30.74% |
| Largest drawdown | -19.37% | -28.35% | -30.23% |
| Positive months | 6/12 | 17/36 | 28/60 |
How much did investing in OFSA3 return?
R$1,000.00 invested on 09/01/2021 would be worth R$1,046.60 today.
- Value today in OFSA3
- R$1,046.60
- Return over the period
- +4.66%
- Return per year
- +0.92%
- In the Ibovespa
- R$1,657.66
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
OFSA3 fundamentals
Valuation
- P/E5.88
- P/B1.68
- EV/EBITDA5.26
- EV/EBIT6.08
- EV/Revenue1.12
- P/EBIT5.53
- P/S1.02
- P/OCF5.98
- P/FCF24.56
- Earnings yield16.45%
- PEG ratio0.07
- Earnings per shareR$4.38
- Book value per shareR$15.33
Debt
- Net debtR$137.1M
- Net debt/EBITDA0.47
- Net debt/Equity0.17
- Debt/Equity0.61
- Current ratio3.61
- Quick ratio2.39
- Cash ratio1.20
Efficiency
- Gross margin52.02%
- EBITDA margin21.27%
- Operating margin18.39%
- Net margin17.29%
- Asset turnover0.85
Profitability
- ROE28.55%
- ROA14.62%
- ROIC25.93%
- Payout29.48%
Growth
- Revenue CAGR (5 years)10.06%
- Earnings CAGR (5 years)14.76%
- Revenue growth (year)19.54%
- Earnings growth (year)65.50%
- Revenue growth (quarter)26.66%
- Earnings growth (quarter)80.39%
What is OFSA3's fair price?
Two classic value formulas, with today's numbers. The current price is R$25.75.
- Graham's fair price
- R$38.85
- 50.87% above the price
√(22.50 × R$4.38 × R$15.33)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- R$20.62
- 19.94% below the price
R$1.24 (5-year average) ÷ 6%
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
OFSA3's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 5.58 | 7.77 | -28.08 | 10.05 | 11.91 | 22.85 | 50.13 | 26.41 |
| P/B | 1.56 | 1.38 | 2.04 | 1.78 | 2.12 | 3.66 | 4.71 | 3.99 |
| EV/EBITDA | 5.38 | 5.21 | 13.06 | 7.45 | 9.35 | 17.13 | 26.51 | 16.52 |
| Dividend yield | 15.37% | 1.74% | 1.82% | 4.58% | 2.88% | 0.59% | 1.04% | 0.96% |
| Earnings per share | R$4.12 | R$2.49 | -R$0.93 | R$2.42 | R$2.11 | R$1.66 | R$0.86 | R$1.28 |
| Book value per share | R$14.77 | R$14.02 | R$12.78 | R$13.64 | R$11.89 | R$10.40 | R$9.13 | R$8.45 |
| ROE | 27.90% | 17.76% | -7.25% | 17.75% | 17.77% | 16.00% | 9.40% | 15.10% |
| ROIC | 22.83% | 16.07% | 0.00% | 16.02% | 14.83% | 13.72% | 7.87% | 12.01% |
| Gross margin | 51.68% | 50.52% | 45.77% | 50.72% | 49.41% | 51.22% | 49.65% | 55.01% |
| EBITDA margin | 22.43% | 21.91% | 12.42% | 20.10% | 18.65% | 17.60% | 15.56% | 20.96% |
| Net margin | 18.15% | 13.11% | -5.30% | 12.55% | 12.59% | 12.29% | 7.47% | 11.68% |
| Net debt/EBITDA | 0.87 | 0.56 | 1.09 | 1.18 | 1.31 | 1.17 | 2.45 | 1.80 |
OFSA3's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | R$1.2B | R$1B | R$943.3M | R$1B | R$905M | R$730.1M |
| Cost of revenue | -R$592M | -R$507.1M | -R$511.5M | -R$513M | -R$457.8M | -R$356.1M |
| Gross profit | R$633M | R$517.7M | R$431.7M | R$528.1M | R$447.2M | R$374M |
| EBITDA | R$274.8M | R$224.5M | R$117.2M | R$209.3M | R$168.8M | R$128.5M |
| EBIT | R$236.5M | R$186.8M | R$81M | R$177.3M | R$141.1M | R$102.1M |
| Financial result | -R$17.2M | -R$9.7M | -R$26.8M | -R$30.3M | -R$15.4M | -R$8.3M |
| Income before tax | R$219.3M | R$177.1M | R$54.3M | R$147.1M | R$125.7M | R$93.8M |
| Income tax | R$3M | -R$42.8M | -R$104.2M | -R$16.4M | -R$11.7M | -R$4.1M |
| Net income | R$222.3M | R$134.3M | -R$50M | R$130.7M | R$114M | R$89.7M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
OFSA3 against its sector
The same indicators for the company's other shares and the sector's largest stocks.
| Stock | P/E | P/B | Dividend yield (12m) | ROE | Market cap |
|---|---|---|---|---|---|
| OFSA3Ourofino | 5.88 | 1.68 | 5.01% | 28.55% | R$1.4B |
| HYPE3HYPERA S.A. | 9.72 | 1.18 | 4.48% | 12.10% | R$17B |
| BLAU3BLAU FARMACÊUTICA S.A. | 10.41 | 1.04 | 8.65% | 10.02% | R$2.4B |
| BIOM3BIOMM S.A. | 26.85 | 2.50 | 0.00% | 9.33% | R$814.3M |
| BALM3BAUMER S.A. | 9.76 | 1.28 | 21.91% | 13.16% | R$178.7M |
| BALM4BAUMER S.A. | 6.42 | 0.84 | 33.31% | 13.16% | R$178.7M |
Does OFSA3 pay dividends?
Dividend yield per year
- 0.00%2017
- 0.96%2018
- 1.04%2019
- 0.59%2020
- 2.88%2021
- 4.58%2022
- 1.82%2023
- 1.74%2024
- 15.37%2025
- 5.01%2026
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 04/16/2026 | 04/30/2026 | R$0.17 |
| Dividend | 04/16/2026 | 04/30/2026 | R$0.19 |
| Interest on equity | 12/23/2025 | 04/30/2026 | R$0.93 |
| Interest on equity | 04/17/2025 | 05/05/2025 | R$0.58 |
| Dividend | 04/17/2025 | 05/05/2025 | R$0.06 |
| Dividend | 04/17/2025 | 05/05/2025 | R$0.09 |
| Interest on equity | 12/20/2024 | 05/05/2025 | R$0.58 |
| Other | 12/30/2024 | 01/31/2025 | R$2.23 |
| Dividend | 04/29/2024 | 05/13/2024 | R$0.34 |
| Interest on equity | 12/19/2023 | 12/28/2023 | R$0.28 |
| Dividend | 04/14/2023 | 05/11/2023 | R$0.20 |
| Interest on equity | 12/16/2022 | 12/29/2022 | R$0.44 |
See all 31 distributions
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 12/16/2022 | 12/29/2022 | R$0.44 |
| Dividend | 04/20/2022 | 05/31/2022 | R$0.24 |
| Interest on equity | 12/17/2021 | 12/29/2021 | R$0.30 |
| Dividend | 04/09/2021 | 04/30/2021 | R$0.17 |
| Interest on equity | 12/23/2020 | 04/30/2021 | R$0.25 |
| Dividend | 10/14/2020 | 10/27/2020 | R$0.19 |
| Interest on equity | 12/19/2019 | 06/23/2020 | R$0.02 |
| Interest on equity | 12/19/2018 | 05/31/2020 | R$0.02 |
| Interest on equity | 12/14/2018 | 05/31/2019 | R$0.13 |
| Dividend | 03/29/2019 | 05/20/2019 | R$0.18 |
| Interest on equity | 12/14/2018 | 05/20/2019 | R$0.14 |
| Interest on equity | 12/19/2017 | 05/31/2018 | R$0.11 |
| Dividend | 04/13/2018 | 04/25/2018 | R$0.03 |
| Dividend | 04/13/2018 | 04/25/2018 | R$0.07 |
| Interest on equity | 12/14/2017 | 04/25/2018 | R$0.11 |
| Interest on equity | 12/21/2015 | 05/09/2016 | R$0.09 |
| Dividend | 04/28/2015 | 05/08/2015 | R$0.18 |
| Dividend | 04/29/2016 | — | R$0.30 |
| Interest on equity | 01/02/2015 | — | R$0.07 |
About Ourofino
- Sector
- Consumo Não Cíclico
- Segment
- Medicamentos e Outros Produtos
- Listing segment
- Novo Mercado
- Tag along
- 100.00%
- Free float
- 42.94%
- Shares issued
- 53.95M common
- Average daily trading
- R$302.3K
- Listed since
- 10/21/2014
- CNPJ
- 20.258.278/0001-70
Ourofino S.A. é uma empresa brasileira especializada em medicamentos e produtos farmacêuticos para saúde animal e humana. A companhia atua no segmento de farmacêutica, oferecendo uma ampla gama de medicamentos, suplementos e produtos de saúde. Ourofino opera com foco em inovação, pesquisa e desenvolvimento de novos produtos, atendendo mercados domésticos e internacionais. A empresa está posicionada como um player importante no segmento farmacêutico brasileiro, contribuindo para a saúde e bem-estar de pessoas e animais.
Investor website| Shareholder | Common | Preferred | Total |
|---|---|---|---|
| Mitsui & Co., Ltd | 29.44% | 0.00% | 29.44% |
| JARDEL MASSARIControlling | 28.76% | 0.00% | 28.76% |
| NORIVAL BONAMICHIControlling | 27.97% | 0.00% | 27.97% |
| Outros | 13.50% | 0.00% | 13.50% |
| Ações Tesouraria | 0.34% | 0.00% | 0.34% |
Questions about OFSA3
How much is OFSA3 today?
OFSA3 is at R$25.75 (1.58% on the day), last traded on 09/30/2026.
How much did OFSA3 pay in dividends in 2025?
OFSA3 paid R$3.54 per share in 2025, a dividend yield of 15.37%.
What are the P/E and P/B of OFSA3?
OFSA3 trades at a P/E of 5.88 and a P/B of 1.68.
How much did OFSA3 return in 12 months?
OFSA3 returned 24.54% in 12 months, with annualized volatility of 25.27% and a largest drawdown of -19.37%.
What sector is OFSA3 in?
Ourofino is in the Consumo Não Cíclico sector, Medicamentos e Outros Produtos segment.